RETRACTED ARTICLE: WFDC2 contributes to epithelial–mesenchymal transition (EMT) by activating AKT signaling pathway and regulating MMP-2 expression

Abstract

Chen Y, Huang L, Wang S, et al. Cancer Manag Res. 2019;11:2415-2424

At the authors request, the Editor and Publisher of Cancer Management and Research wish to retract the published article. The authors have informed the journal that they have concerns regarding the reliability of the published Western blot results and cannot locate or provide any original Western blot data relating to their study. The authors can no longer verify the findings as reported and the Editor has agreed with the request to retract the article.

Our decision-making was informed by our policy on publishing ethics and integrity and the COPE guidelines on retraction.

The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as “Retracted”.

Keywords:

• WFCD2
• ovarian cancer
• metastasis
• cell migration and invasion
• epithelial-mesenchymal transition

View retraction statement:

WFDC2 Contributes to Epithelial–Mesenchymal Transition (EMT) by Activating AKT Signaling Pathway and Regulating MMP-2 Expression [Retraction]